Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
An Overview of Regorafenib in Gastrointestinal Cancers: A Lunch Clinical Research Update
The Complicated Landscape of 2L HCC: Where Does Regorafenib Fit?
Saturday, July 2, 2022
14:30 – 14:45
Location: Rooms 133-134; Level 1
Session Speaker(s)
Richard Finn, MD
Geffen School of Medicine at UCLA
Santa Monica, United States
Learning Objectives:
REFINE study+ regorafenib mono after IO
RWEs
